RUNX3 and acute myeloid leukemia: These findings support a recent study that identified RUNX3 as one of three super-enhancer associated genes that is abnormally overexpressed in AML cells compared to normal hematopoietic cells, such as neutrophils, monocytes, and HSPC [39].